Summary Vitamin D receptor (VDR) is a nuclear receptor that regulates the expression of genes involved in calcium homeostasis. Activation of VDR is thought to be a promising drug target for osteoporosis. Using a VDR-driven luciferase expression assay for screening a naturally occurring food component, we identified quercetin as a VDR activator. Quercetin also activated the GAL4 DNA-binding domain fused to the VDR ligand-binding domain. Moreover, it was confirmed that quercetin increases the mRNA level of TRPV6, which is a VDR target gene, in Caco-2 cells. These results indicate that quercetin enhances VDR activity through the alteration of cofactor recruitment, thereby stimulating its target genes while providing a new function for quercetin as the VDR activator.
1 ␣ ,25-Dihydroxyvitamin D3 [1, 2 D 3 ], the biologically active metabolite of vitamin D, is required for calcium homeostasis, normal skeletal development, and the maintenance of skeletal architecture. It is believed that the biological functions of 1,25-(OH) 2 D 3 are mainly exerted through the vitamin D receptor (VDR) mediated control of target genes. VDR is a nuclear receptor that binds ligands, including 1,25-(OH) 2 D 3 . This binding triggers an association between VDR and its heterodimer partner, RXR; the heterodimer recognizes a VDR-responsive element in the promoter and enhancer region of VDR-regulated genes ( 1 ) . The ligand binding to VDR also alters the recruitment of cofactors, including SRCs, CBP/p300, corepressor/HDAC complex and others (2) (3) (4) (5) (6) , thereby regulating their target gene expression. VDR ligands such as calcitriol (1,25- (OH) 2 D 3 ) and its synthetic analog, alfacalcidol (1 ␣ -hydroxyvitamin D 3 ), have been approved for the treatment of osteoporosis.
Quercetin, one of the most abundant flavonoids present in leaf vegetables and teas ( 7 ) , has a wide range of biological effects such as antiatherogenic effects ( 8 , 9 ) , antiproliferative effects on many cancer cell lines (10) (11) (12) , and amelioration of metabolic syndrome abnormalities, which include obesity, dyslipidemia, insulin resistance, and hypertension ( 8 , 13-15 ) . These beneficial effects have been attributed mainly to quercetin's antioxidative potency and protein-function modulating activity.
In this study, we conducted two kinds of cell-based luciferase expression assays that assessed the VDR activity to screen a library of naturally occurring food components. We found that quercetin was identified as a VDR activator and that it stimulated TRPV6 gene expression in undifferentiated and differentiated Caco-2 cells.
MATERIALS AND METHODS
Materials. 2-Hydroxyflavanone, piperine, rhamnetin, and sulfuretin were from Extrasynthese. Quercetin was from Jena Bioscience. ( R , S )-Equol was from LC Laboratories. Dulbecco's Modified Eagle's Medium (DMEM) was from Wako Pure Chemical Industries, Ltd., Osaka, Japan.
Cell culture. HEK293 cells were maintained in medium A [DMEM supplemented with 100 units/mL penicillin, 100 g/mL streptomycin, and 10% fetal bovine serum (FBS)]. Caco-2 cells were maintained in medium B (DMEM supplemented with 100 units/mL penicillin, 100 g/mL streptomycin, nonessential amino acids, and 10% FBS). The cells that had been cultured for 10 d after confluency were considered differentiated. Cells were incubated at 37˚C under 5% CO 2 atmosphere.
Plasmid constructs. Expression plasmids for a fulllength rat VDR (pH ␤ APr-1-rVDR) and for the ligandbinding domain (LBD) of VDR fused to the DNA-binding domain (DBD) of yeast GAL4 (pGal4-DBD-VDR-LBD) were kindly provided by Dr. Jun-ichi Nishikawa (Mukogawa Women's University). To construct an artificial reporter plasmid, pGL-P mSpp1 ϫ 3 (which was also provided by Dr. Jun-ichi Nishikawa), a VDR-responsive element of the mouse Spp-1 gene promoter, was repeated three times and inserted into a pGL3 promoter, vector (Promega). A reporter plasmid, pG5Luc, containing five copies of GAL4-binding sites, has been described previously ( 16 ) .
Luciferase assays. HEK293 cells were plated in 12-well plates at a density of 1.0 ϫ 10 5 cells/well, cultured with medium A for 20 h, and then transfected with 150 ng of one of the reporter plasmids, 50 ng of pCMV-␤ -Gal which is an expression plasmid for ␤ -galactosidase, and 200 ng of each expression plasmid by the calcium phosphate method. Four hours after transfection, the medium was replaced with the DMEM medium supplemented with 10% dextran-charcoal-stripped FBS. Twenty-four hours later, the indicated test compounds were added. After incubation for another 24 h, the luciferase and ␤ -galactosidase activities were measured as described previously ( 17 ) . Normalized luciferase values were determined by dividing luciferase activity by the ␤ -galactosidase activity.
Real-time PCR. Total RNA was extracted from Caco-2 cells using an RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. cDNA was synthesized and amplified from 2 g total RNA using a high capacity cDNA reverse transcription kit (Applied Biosystems). Quantitative real-time PCR (Taqman probe and SYBR green) analysis was performed on an Applied Biosystems 7000 Sequence Detection System. Expression was normalized to the GAPDH control. The TaqMan ID number for GAPDH is 4352934. The sequences of the primer sets used were as follows: TRPV6, 5 ′ -ACTGT-CATTGGGGCTATCATC-3 ′ and 5 ′ -CAGCAGAATCGCAT-CAGGTC-3 ′ ( 18 ).
Statistical analysis. All data are presented as mean Ϯ SD. Statistical analysis was performed using StatView software. One-way ANOVA followed by the Bonferroni/Dunn procedure was used to compare more than two groups.
RESULTS

Screening of VDR activators using a VDR-driven luciferase expression assay (Experiment 1)
To identify VDR activators, we used a cell-based luciferase expression assay and screened a library of 200 commercially available naturally occurring food components. HEK293 cells, which were established from human embryonic kidney and used for transfection experiments because of high transfection efficiency, were transfected with a full-length VDR expression plasmid together with a luciferase reporter gene containing three copies of the VDR responsive elements and a ␤ -galactosidase-expressing plasmid for normalization.
We used all test compounds at 100 M for screening. We identified six compounds that enhance the VDR activity more than twofold compared to vehicle treatment (Table 1) . Quercetin was selected for further characterization because it was the most potent VDR activator in this study.
To confirm the effect of quercetin on the VDR activity, we repeated the VDR-driven luciferase expression assay with low doses of quercetin. Treatment with quercetin stimulated the VDR activity in a dose-dependent manner and 10 M quercetin was sufficient for activating VDR (Fig. 1) . However, 1,25-(OH) 2 D 3 , a natural VDR ligand, significantly stimulated the VDR activity at 10 p M , indicating that quercetin is a weak activator of VDR.
Quercetin activates GAL4 DBD to VDR-LBD (Experiment 2)
In order to determine whether quercetin would enhance the activity of VDR-LBD, we employed a heterologous GAL4 system using an expression plasmid, encoding an LBD of VDR coupled to the DBD of yeast GAL4 (pGal4-DBD-VDR-LBD). HEK293 cells were transfected with pGAL4-DBD-VDR-LBD together with a luciferase reporter gene containing five repeats of GAL4-upstream-activating sequence (pG5Luc) and a ␤ -galactosidase-expressing plasmid for normalization. While treatment with 1,25-(OH) 2 D 3 stimulated VDR-LBD at 10 p M , quercetin stimulated the activity of VDR-LBD at 10 M and 100 M , respectively (Fig. 2) . These results imply that quercetin enhances the VDR activity All data are presented as means Ϯ SD values of experiments performed in duplicate ( n ϭ 2). VDR activation potency was determined in the same manner as described for Fig. 1 . Fig. 1 . Quercetin induces VDR-mediated transcriptional activity in a transactivation assay. HEK293 cells were transfected with 200 ng of an expression plasmid for full-length VDR, pH ␤ APr-1-rVDR, 150 ng of a reporter plasmid, pGL-P mSpp1 ϫ 3 containing three copies of VDR-responsive elements, and 50 ng of pCMV-␤ -Gal. Four hours after transfection, the medium was replaced with DMEM medium supplemented with 10% dextran-charcoal-stripped FBS. Twenty-four hours later, indicated test compounds were added. After incubation for another 24 h, the luciferase assays were performed as described under "Materials and Methods." All data are presented as mean Ϯ SD and represent at least three independent experiments. ** p Ͻ 0.01.
at least through the alteration of cofactor recruitment.
Quercetin stimulates TRPV6 gene expression in undifferentiated and differentiated Caco-2 cells (Experiment 3)
Next, as quercetin seemed to function as an activator for VDR, the impact of quercetin on a VDR target gene was evaluated. Undifferentiated and differentiated Caco-2 cells, which were established from human epithelial colorectal adenocarcinoma, were treated with indicated doses of quercetin for 12 h and then TRPV6 gene expression was analyzed by real-time PCR. In undifferentiated Caco-2 cells, TRPV6 gene expression increased by three to fourfold on treatment with quercetin at 30 M and 100 M , respectively (Fig. 3) . TRPV6 gene expression increased approximately fourfold over a 14-d culture, which caused Caco-2 cells to differentiate into enterocytes. It was also found that 100 M quercetin treatment significantly stimulated TRPV6 gene expression in differentiated Caco-2 cells. These results suggest that quercetin functioned as an activator of VDR in undifferentiated and differentiated Caco-2 cells.
DISCUSSION
In the present study, we have attempted to identify naturally occurring food components that enhance the VDR activity. For this purpose, we conducted a cellbased luciferase expression assay using a VDR-driven promoter. Among ~200 compounds, six were identified as possible candidates of VDR activators. The ability of quercetin, one of the most abundant flavonoids present in leaf vegetables and teas, to enhance the function of the VDR activator was also confirmed by another luciferase expression assay, which assesses the activity of GAL4 DBD fused to VDR-LBD. Presently, it is not clear how quercetin enhances the VDR activity. It has been reported that quercetin suppresses the function of the androgen receptor, a member of the nuclear receptor superfamily, through the enhancement of protein-protein interactions among Sp1, c-Jun, and the androgen receptor in a human prostate adenocarcinoma cell line, LNCaP ( 19 , 20 ) . Thus, it is conceivable that activation of VDR by quercetin is mediated by VDR alteration of protein-protein interaction with unidentified factor(s). It is also probable that quercetin affects the VDR activity through direct binding to VDR-LBD like a common ligand. Further studies will be required to determine how quercetin enhances the VDR activity.
The current data also demonstrate that quercetin stimulates TRPV6 gene expression in undifferentiated and differentiated Caco-2 cells, suggesting that quercetin can activate the endogenous VDR. It has been considered that TRPV6, which is a calcium channel found on the luminal side of the epithelial cells ( 21 ) , functions as a gatekeeper of calcium entry across epithelia. A previous study demonstrated that 1,25-(OH) 2 D 3 -induced TRPV6 mRNA level is significantly greater in differentiated Caco-2 cells than in undifferentiated Caco-2 cells ( 22 ) . It should be noted that quercetin efficiently increased the level of TRPV6 mRNA in undifferentiated Caco-2 cells rather than in differentiated Caco-2 cells in the present study. A possible mechanism of this difference in stimulation may be due to the difference of cofactors that are recruited to VDR by the treatment with quercetin and 1,25-(OH) 2 D 3 .
VDR activity plays a key role in controlling calcium containing five copies of the GAL4 binding sites, and 50 ng of pCMV-␤ -Gal. Four hours after transfection, the medium was replaced with DMEM medium supplemented with 10% dextran-charcoal-stripped FBS. Twenty-four hours later, indicated test compounds were added. After incubation for another 24 h, the luciferase assays were performed as described under "Materials and Methods." All data are presented as mean Ϯ SD values of three independent experiments. * p Ͻ 0.05, ** p Ͻ 0.01. absorption from epithelia and its activation has been proposed as a therapeutic target in the treatment of osteoporosis. In the present study, we identified quercetin aglycon as a VDR activator and 100 M quercetin enhanced the expression of TRPV6 mRNA in differentiated Caco-2 cells. Since TRPV6 is expressed predominantly at the upper part of the small intestine, it is important to maintain the concentration needed to be effective in the epithelial cells of this region. Although quercetin is present in plants almost exclusively as ␤ -glycosides, quercetin monoglucosides such as isoquercetin are absorbed from the small intestine after enzymatic hydrolysis ( 23 , 24 ) . Whether a sufficient amount of quercetin monoglucoside is absorbed and it is effective to enhance TRPV6 expression in the upper small intestine remains an open question. In terms of quercetin supplement, it was reported that its ingestion (200-500 mg) results in up to 100 M quercetin aglycon at the small intestinal lumen ( 25 ) . It seems therefore likely that quercetin aglycon supplementation gives rise to stimulated TRPV6 gene expression in the upper small intestine. Consequently, supplemental quercetin consumption may improve calcium absorption from epithelia. Further studies are needed to evaluate the effect of quercetin on the calcium absorption in in vitro culture cells as well as in vivo animal models.
